Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 22 (2) , 230-236
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysisBone, 2016
- Spinal Orthoses for Vertebral Osteoporosis and Osteoporotic Vertebral Fracture: A Systematic ReviewArchives of Physical Medicine and Rehabilitation, 2016
- Effect of osteoporosis medications on fracture healingOsteoporosis International, 2015
- Update on Denosumab Treatment in Postmenopausal Women with OsteoporosisEndocrinology and Metabolism, 2015
- Comparative Study of the Treatment Outcomes of Osteoporotic Compression Fractures without Neurologic Injury Using a Rigid Brace, a Soft Brace, and No BraceJournal of Bone and Joint Surgery, 2014
- A Review of Osteoporotic Vertebral Fracture Nonunion ManagementSpine, 2014
- Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)The Journal of Clinical Endocrinology & Metabolism, 2014
- Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosisOsteoporosis International, 2011
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2009